Research Article
Volume 5 Issue 6 - 2022
Long Term Covid-19 Syndrome in Non-Hospitalized Patient a Cross-Sectional Study
Ramy Ibrahim*, Jose Ruben Hermann, Maria Amanda Arauz, Kenneth S Roca, Essam Khalil, Irina Dashkova, Anna Dashkova and Ebram Said
Internal Medicince, Medical Director of Premier Medical Associates, USA
*Corresponding Author: Ramy Ibrahim, Internal Medicince, Medical Director of Premier Medical Associates, USA.
Received: June 06, 2022; Published: June 20, 2022




Abstract

Introduction: COVID-19 exposes patients to new, recurrent, or ongoing conditions that affect their health. Patients experience different symptoms that can last beyond 12 weeks after first being infected with COVID- 19 (Post Covid-19 syndrome). Even the acutely asymptomatic patients later developed Post Covid-19 syndrome. These circumstances can present as diverse types or combinations of health problems for different lengths of time.

Methods: This is a cross-sectional study of 217 SARS‐CoV‐2 laboratory‐positive patients (SARS‐CoV‐2+) between March 2020 and July 2021. Inclusion criteria: all patients 18 years and older with a previous diagnosis of COVID-19. Charts were reviewed to find patients with persistent problems after a COVID-19 infection or new diagnosis during the acute infection that persisted or appeared 12 weeks after having a SARS-CoV-2 positive test. Also, we designed a population-based survey to assess the persistence of the symptoms. No protected health information was collected, and verbal consent obtained.

Results: Of 217 patients included in the study, the median age was 68 years old, and the most common long terms effects of COVID-19 were anosmia and ageusia at 15.7% followed by dyspnea with 7.8%. Depression was diagnosed in 6% of patients. Cardiopulmonary, neurologic, and gastrointestinal symptoms were also found to be present in several patients.

Conclusions: COVID-19 may cause multiorgan system impairment with many survivors experiencing cardiovascular, respiratory, neurological, psychiatric, and gastrointestinal system compromise.

Keywords: Long Term COVID-19 Effect; Complication; SARS-Cov-2; Anosmia; Ageusia; Dyspnea; Depression

References

  1. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 (2020).
  2. Abdullah F., et al. “Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south Africa”. The International Journal of Infectious Diseases 116 (2022): 38-42.
  3. Petrilli CM., et al. “Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study”. British Medical Journal 22 (2020): 369.
  4. Post-COVID Conditions | CDC (2021).
  5. Carfì A., et al. “Persistent symptoms in patients after acute COVID-19”. JAMA - Journal of the American Medical Association. American Medical Association 324 (2020): 603-605.
  6. Puntmann VO., et al. “Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19)”. JAMA Cardiology11 (2020): 1265-1273.
  7. What It Means to Be a Coronavirus “Long-Hauler” – Health Essentials from Cleveland Clinic (2021).
  8. Zoller M., et al. Coronavirus disease Der Anaesthesist 69 (2020).
  9. Long-Haul COVID-19 May Be a Public Health Crisis After the Pandemic (2021).
  10. Rubin R. “As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts”. The Journal of the American Medical Association 14 (2020): 1381-1383.
  11. Greenhalgh T., et al. “Management of post-acute covid-19 in primary care”. British Medical Journal 11 (2020): 370.
  12. Tenforde MW., et al. “Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March–June 2020”. Morbidity and Mortality Weekly Report 30 (2020): 993-998.
  13. Del Rio C., et al. “Long-term Health Consequences of COVID-19”. JAMA - Journal of the American Medical Association American Medical Association 324 (2020): 1723-1724.
  14. Metlay JP., et al. “Measuring symptomatic and functional recovery in patients with community-acquired pneumonia”. Journal of General Internal Medicine 7 (1997): 423-430.
  15. Landi F., et al. “Post-COVID-19 global health strategies: the need for an interdisciplinary approach”. Aging Clinical and Experimental Research8 (2020): 1613-1620.
  16. Havervall S., et al. “Symptoms and Functional Impairment Assessed 8 Months after Mild COVID-19 among Health Care Workers”. JAMA - Journal of the American Medical Association American Medical Association 325 (2021): 2015-2016.
  17. Shi S., et al. “Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China”. JAMA Cardiology 7 (2020): 802-810.
  18. Li H., et al. “SARS-CoV-2 and viral sepsis: observations and hypotheses”. The Lancet 395 (2020): 1517-1520.
  19. Kindermann I., et al. “Predictors of outcome in patients with suspected myocarditis”. Circulation6 (2008): 639-648.
  20. Grn S., et al. “Long-term follow-up of biopsy-proven viral myocarditis: Predictors of mortality and incomplete recovery”. Journal of the American College of Cardiology18 (2012): 1604-1615.
  21. Rajpal S., et al. “Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering from COVID-19 Infection”. JAMA Cardiology American Medical Association 6 (2021): 116-118.
  22. Zhao Y miao., et al. “Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery”. EClinical Medicine 25 (2020): 100463.
  23. Huang Y., et al. “Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase”. Respiratory Research BioMed Central 21 (2020): 163.
  24. Zubair AS., et al. “Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review”. JAMA Neurology American Medical Association 77 (2020): 1018-1027.
  25. Nauen DW., et al. “Assessing Brain Capillaries in Coronavirus Disease 2019”. JAMA Neurology6 (2021): 760-762.
  26. Pennisi M., et al. “Sars-cov-2, and the nervous system: From clinical features to molecular mechanisms”. International Journal of Molecular Sciences 21 (2020): 1-21.
  27. Suzuki K. “Coronavirus disease 2019 (COVID-19) and headaches”. Journal of Clinical Neurology9 (2020): 589-596.
  28. Mao L., et al. “Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China”. JAMA Neurology6 (2020): 683-690.
  29. Vaira LA., et al. “Anosmia and Ageusia: Common Findings in COVID-19 Patients”. Laryngoscope 7 (2020): 1787.
  30. Lechien JR., et al. “Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study”. European Archives of Oto-Rhino-Laryngology8 (2020): 2251-2261.
  31. Koumpa FS., et al. “Sudden irreversible hearing loss post COVID-19”. BMJ Case Reports 11 (2020).
  32. Degen C., et al. “Acute Profound Sensorineural Hearing Loss After COVID-19 Pneumonia”. Mayo Clinic Proceedings 95 (2020): 1801-1803.
  33. Kalcioglu MT., et al. “Can COVID-19 cause sudden sensorineural hearing loss?” International Journal of Infectious Diseases 101 (2020): 205.
  34. Merchant SN., et al. “Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss”. Otology and Neurotology 2 (2005): 15-160.
  35. Heckmann JG., et al. The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell’s Palsy) (2019).
  36. Wan Y., et al. Coronavirus disease 2019 complicated with Bell’s palsy: a case report (2020): 1-7.
  37. Codeluppi L., et al. “Facial palsy during the COVID-19 pandemic”. Brain and Behavior 1 (2021).
  38. Islamoglu Y., et al. “Facial paralysis as the only symptom of COVID-19: A prospective study”. American Journal of Otolaryngology and Head and Neck Surgery 4 (2021): 102956.
  39. Soeiro T., et al. “Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy”. Therapies (2021): 5-6.
  40. Galea S., et al. “The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention”. JAMA Internal Medicine. American Medical Association 180 (2020): 817-818.
  41. Morin L., et al. “Four-Month Clinical Status of a Cohort of Patients after Hospitalization for COVID-19”. JAMA - Journal of the American Medical Association American Medical Association15 (2021): 1525-1534.
  42. Prescott HC. “Outcomes for Patients following Hospitalization for COVID-19”. JAMA - Journal of the American Medical Association American Medical Association 325 (2021): 1511-1512.
  43. Margolis KG., et al. “The Microbiota-Gut-Brain Axis: From Motility to Mood”. Gastroenterology 160 (2021): 1486-1501.
  44. Gurusamy SR., et al. “Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis”. The American Journal of Gastroenterology5 (2021): 935-942.
  45. Al-Aly Z., et al. “High-dimensional characterization of post-acute sequelae of COVID-19”. Nature 7862 (2021): 259-264.
  46. Jin X., et al. “Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms”. Gut6 (2020): 1002-1009.
  47. Post-COVID-19 GI Symptoms: Are We in for the Long Haul? (2021).
  48. Kaźmierczak-Siedlecka K., et al. “COVID-19 – Gastrointestinal and gut microbiota-related aspects”. European Review for Medical and Pharmacological Sciences 20 (2020): 10853-10859.
  49. Xiao F., et al. “Evidence for Gastrointestinal Infection of SARS-CoV-2”. Gastroenterology 6 (2020): 1831-1833.
  50. Marasco G., et al. “Implications of SARS-CoV-2 infection for neurogastroenterology”. Neurogastroenterology and Motility 33 (2021).
  51. Mohandas S and Vairappan B. “Severe acute respiratory syndrome coronavirus-2 infection and the gut–liver axis”. Journal of Digestive Diseases 21 (2020): 687-695.
  52. Cha MH., et al. “Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review”. World Journal of Gastroenterology 26 (2020): 2323-2332.
  53. Roth NC., et al. “Post–COVID-19 Cholangiopathy: A Novel Entity”. The American Journal of Gastroenterology5 (2021): 1077-1082.
  54. Fernández-De-las-peñas C., et al. “Defining post-covid symptoms (post-acute covid, long covid, persistent post-covid): An integrative classification”. International Journal of Environmental Research and Public Health 18 (2021): 1-9.
  55. COVID-19 Map - Johns Hopkins Coronavirus Resource Center (2021).
  56. Zhou Z., et al. “Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms”. Journal of Neurology 267 (2020): 2179-2184.
  57. Li YC., et al. “The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients”. Journal of Medical Virology 92 (2020): 552-555.
Citation: Gurpreet Kaur. “Tooth Banking- A Revolution: Mini Review”. EC Clinical and Medical Case Reports 5.6 (2022): 104-112.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before August 18, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.